protein ladder precision plus proteintm unstained protein standard Search Results


precision plus proteintm all blue standards  (Bio-Rad)
96
Bio-Rad precision plus proteintm all blue standards
Precision Plus Proteintm All Blue Standards, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+ladder+precision+plus+proteintm+unstained+protein+standard/Precision+Plus+Protein+All+Blue+Standards/pmc06273553-144-0-6
Average 96 stars, based on 1 article reviews
precision plus proteintm all blue standards - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
sds page  (Bio-Rad)
96
Bio-Rad sds page
Sds Page, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+ladder+precision+plus+proteintm+unstained+protein+standard/Precision+Plus+Protein+Unstained+Protein+Standards/10__3390_slash_biom15030319-111-13-14
Average 96 stars, based on 1 article reviews
sds page - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
precision plus proteintm dual color standards  (Bio-Rad)
97
Bio-Rad precision plus proteintm dual color standards
Precision Plus Proteintm Dual Color Standards, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+ladder+precision+plus+proteintm+unstained+protein+standard/Precision+Plus+Protein+Dual+Color+Standards/pmc10915164__41467_2024_46303_MOESM1_ESM-10-0-30
Average 97 stars, based on 1 article reviews
precision plus proteintm dual color standards - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier
proteontm gcl sensor chip  (Bio-Rad)
94
Bio-Rad proteontm gcl sensor chip
Proteontm Gcl Sensor Chip, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+ladder+precision+plus+proteintm+unstained+protein+standard/ProteOn+GLC+Sensor+Chip/pmc04455283__srep10819___s1-37-15-19
Average 94 stars, based on 1 article reviews
proteontm gcl sensor chip - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
precision plus proteintm kaleidoscopetm prestained protein standards  (Bio-Rad)
99
Bio-Rad precision plus proteintm kaleidoscopetm prestained protein standards
Precision Plus Proteintm Kaleidoscopetm Prestained Protein Standards, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+ladder+precision+plus+proteintm+unstained+protein+standard/Precision+Plus+Protein+Kaleidoscope+Prestained+Protein+Standards/pm40054709-84-21-28
Average 99 stars, based on 1 article reviews
precision plus proteintm kaleidoscopetm prestained protein standards - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier
precision plus proteintm standards  (Bio-Rad)
96
Bio-Rad precision plus proteintm standards
Precision Plus Proteintm Standards, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+ladder+precision+plus+proteintm+unstained+protein+standard/Precision+Plus+Protein+Standard+Plugs/pmc02693066-144-0-4
Average 96 stars, based on 1 article reviews
precision plus proteintm standards - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
kaleidoscope  (Bio-Rad)
96
Bio-Rad kaleidoscope
Figure 2: Western blotting detection of GnRH-I fusion protein obtained from transfected COS 1 cells and labelled with anti- GnRH-I (left) and anti V5 antibodies (right). The first [10], second [6] and the new vaccines were used to transfect COS 1 cells. Lane 1 shows the <t>Kaleidoscope</t> ladder, lanes 2, 3 and 4 containing transfected COS1 cell lysate of the first, second and new vaccines respectively. Lanes 6, 7 and 8 containing transfected COS1 cell culture supernatant of the first, second and new vaccine repectively. Lane 5 and 9 containing non-transfected COS1 cell lysate and culture supernatant respectively (negative control) and lane 10 lacking both anti-GnRH-I (left) and anti V5 antibodies (right) in the Western blotting detection of the fusion protein. The newly engineered vaccine produce fusion protein (35.216 KD) detected both in cell lysate (lane 4) and cell culture supernatant (lane 8). GnRH-I fusion protein (17.138 KD) of the first vaccine (lane 2) was detected in the cell lysate (lane 6). GnRH-I fusion protein (18.871 KD) of the second vaccine was detected both in cell lysate (lane 3) and cell culture supernatant (lane 7). GnRH-I fusion protein was not detected in any of the control lane 5, 9 and 10.
Kaleidoscope, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+ladder+precision+plus+proteintm+unstained+protein+standard/Precision+Plus+Protein+Kaleidoscope+Standards/10__4172_slash_2157___7560__1000282-50-1-5
Average 96 stars, based on 1 article reviews
kaleidoscope - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
molecular weight markers  (Bio-Rad)
99
Bio-Rad molecular weight markers
Figure 2: Western blotting detection of GnRH-I fusion protein obtained from transfected COS 1 cells and labelled with anti- GnRH-I (left) and anti V5 antibodies (right). The first [10], second [6] and the new vaccines were used to transfect COS 1 cells. Lane 1 shows the <t>Kaleidoscope</t> ladder, lanes 2, 3 and 4 containing transfected COS1 cell lysate of the first, second and new vaccines respectively. Lanes 6, 7 and 8 containing transfected COS1 cell culture supernatant of the first, second and new vaccine repectively. Lane 5 and 9 containing non-transfected COS1 cell lysate and culture supernatant respectively (negative control) and lane 10 lacking both anti-GnRH-I (left) and anti V5 antibodies (right) in the Western blotting detection of the fusion protein. The newly engineered vaccine produce fusion protein (35.216 KD) detected both in cell lysate (lane 4) and cell culture supernatant (lane 8). GnRH-I fusion protein (17.138 KD) of the first vaccine (lane 2) was detected in the cell lysate (lane 6). GnRH-I fusion protein (18.871 KD) of the second vaccine was detected both in cell lysate (lane 3) and cell culture supernatant (lane 7). GnRH-I fusion protein was not detected in any of the control lane 5, 9 and 10.
Molecular Weight Markers, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+ladder+precision+plus+proteintm+unstained+protein+standard/Precision+Plus+Protein+Dual+Xtra+Prestained+Protein+Standards/10__1016_slash_j__foodhyd__2025__112066-217-0-12
Average 99 stars, based on 1 article reviews
molecular weight markers - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier
proteontm xpr36  (Bio-Rad)
96
Bio-Rad proteontm xpr36
Figure 2: Western blotting detection of GnRH-I fusion protein obtained from transfected COS 1 cells and labelled with anti- GnRH-I (left) and anti V5 antibodies (right). The first [10], second [6] and the new vaccines were used to transfect COS 1 cells. Lane 1 shows the <t>Kaleidoscope</t> ladder, lanes 2, 3 and 4 containing transfected COS1 cell lysate of the first, second and new vaccines respectively. Lanes 6, 7 and 8 containing transfected COS1 cell culture supernatant of the first, second and new vaccine repectively. Lane 5 and 9 containing non-transfected COS1 cell lysate and culture supernatant respectively (negative control) and lane 10 lacking both anti-GnRH-I (left) and anti V5 antibodies (right) in the Western blotting detection of the fusion protein. The newly engineered vaccine produce fusion protein (35.216 KD) detected both in cell lysate (lane 4) and cell culture supernatant (lane 8). GnRH-I fusion protein (17.138 KD) of the first vaccine (lane 2) was detected in the cell lysate (lane 6). GnRH-I fusion protein (18.871 KD) of the second vaccine was detected both in cell lysate (lane 3) and cell culture supernatant (lane 7). GnRH-I fusion protein was not detected in any of the control lane 5, 9 and 10.
Proteontm Xpr36, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+ladder+precision+plus+proteintm+unstained+protein+standard/ProteOn+XPR36+Protein+Interaction+Array+System/10__1016_slash_s1535___9476_ascii40_20_ascii41_34934___3-125-7-28
Average 96 stars, based on 1 article reviews
proteontm xpr36 - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
mini proteantm tetra system  (Bio-Rad)
97
Bio-Rad mini proteantm tetra system
Figure 2: Western blotting detection of GnRH-I fusion protein obtained from transfected COS 1 cells and labelled with anti- GnRH-I (left) and anti V5 antibodies (right). The first [10], second [6] and the new vaccines were used to transfect COS 1 cells. Lane 1 shows the <t>Kaleidoscope</t> ladder, lanes 2, 3 and 4 containing transfected COS1 cell lysate of the first, second and new vaccines respectively. Lanes 6, 7 and 8 containing transfected COS1 cell culture supernatant of the first, second and new vaccine repectively. Lane 5 and 9 containing non-transfected COS1 cell lysate and culture supernatant respectively (negative control) and lane 10 lacking both anti-GnRH-I (left) and anti V5 antibodies (right) in the Western blotting detection of the fusion protein. The newly engineered vaccine produce fusion protein (35.216 KD) detected both in cell lysate (lane 4) and cell culture supernatant (lane 8). GnRH-I fusion protein (17.138 KD) of the first vaccine (lane 2) was detected in the cell lysate (lane 6). GnRH-I fusion protein (18.871 KD) of the second vaccine was detected both in cell lysate (lane 3) and cell culture supernatant (lane 7). GnRH-I fusion protein was not detected in any of the control lane 5, 9 and 10.
Mini Proteantm Tetra System, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+ladder+precision+plus+proteintm+unstained+protein+standard/Mini-PROTEAN+Tetra+Cell/pm37932372-553-58-62
Average 97 stars, based on 1 article reviews
mini proteantm tetra system - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier
bio rad proteantm plus dodecatm cell  (Bio-Rad)
94
Bio-Rad bio rad proteantm plus dodecatm cell
Figure 2: Western blotting detection of GnRH-I fusion protein obtained from transfected COS 1 cells and labelled with anti- GnRH-I (left) and anti V5 antibodies (right). The first [10], second [6] and the new vaccines were used to transfect COS 1 cells. Lane 1 shows the <t>Kaleidoscope</t> ladder, lanes 2, 3 and 4 containing transfected COS1 cell lysate of the first, second and new vaccines respectively. Lanes 6, 7 and 8 containing transfected COS1 cell culture supernatant of the first, second and new vaccine repectively. Lane 5 and 9 containing non-transfected COS1 cell lysate and culture supernatant respectively (negative control) and lane 10 lacking both anti-GnRH-I (left) and anti V5 antibodies (right) in the Western blotting detection of the fusion protein. The newly engineered vaccine produce fusion protein (35.216 KD) detected both in cell lysate (lane 4) and cell culture supernatant (lane 8). GnRH-I fusion protein (17.138 KD) of the first vaccine (lane 2) was detected in the cell lysate (lane 6). GnRH-I fusion protein (18.871 KD) of the second vaccine was detected both in cell lysate (lane 3) and cell culture supernatant (lane 7). GnRH-I fusion protein was not detected in any of the control lane 5, 9 and 10.
Bio Rad Proteantm Plus Dodecatm Cell, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+ladder+precision+plus+proteintm+unstained+protein+standard/PROTEAN+Plus+Dodeca+Cell/pmc02806823-354-10-10
Average 94 stars, based on 1 article reviews
bio rad proteantm plus dodecatm cell - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

Image Search Results


Figure 2: Western blotting detection of GnRH-I fusion protein obtained from transfected COS 1 cells and labelled with anti- GnRH-I (left) and anti V5 antibodies (right). The first [10], second [6] and the new vaccines were used to transfect COS 1 cells. Lane 1 shows the Kaleidoscope ladder, lanes 2, 3 and 4 containing transfected COS1 cell lysate of the first, second and new vaccines respectively. Lanes 6, 7 and 8 containing transfected COS1 cell culture supernatant of the first, second and new vaccine repectively. Lane 5 and 9 containing non-transfected COS1 cell lysate and culture supernatant respectively (negative control) and lane 10 lacking both anti-GnRH-I (left) and anti V5 antibodies (right) in the Western blotting detection of the fusion protein. The newly engineered vaccine produce fusion protein (35.216 KD) detected both in cell lysate (lane 4) and cell culture supernatant (lane 8). GnRH-I fusion protein (17.138 KD) of the first vaccine (lane 2) was detected in the cell lysate (lane 6). GnRH-I fusion protein (18.871 KD) of the second vaccine was detected both in cell lysate (lane 3) and cell culture supernatant (lane 7). GnRH-I fusion protein was not detected in any of the control lane 5, 9 and 10.

Journal: Journal of Vaccines & Vaccination

Article Title: Immunization of Female Mice with a Plasmid DNA Vaccine Coding Eight Repeats of Gonadotrophin Releasing Hormone(Gnrh-I) and Eight T-Helper Epitopes Suppress Fertility In Vivo

doi: 10.4172/2157-7560.1000282

Figure Lengend Snippet: Figure 2: Western blotting detection of GnRH-I fusion protein obtained from transfected COS 1 cells and labelled with anti- GnRH-I (left) and anti V5 antibodies (right). The first [10], second [6] and the new vaccines were used to transfect COS 1 cells. Lane 1 shows the Kaleidoscope ladder, lanes 2, 3 and 4 containing transfected COS1 cell lysate of the first, second and new vaccines respectively. Lanes 6, 7 and 8 containing transfected COS1 cell culture supernatant of the first, second and new vaccine repectively. Lane 5 and 9 containing non-transfected COS1 cell lysate and culture supernatant respectively (negative control) and lane 10 lacking both anti-GnRH-I (left) and anti V5 antibodies (right) in the Western blotting detection of the fusion protein. The newly engineered vaccine produce fusion protein (35.216 KD) detected both in cell lysate (lane 4) and cell culture supernatant (lane 8). GnRH-I fusion protein (17.138 KD) of the first vaccine (lane 2) was detected in the cell lysate (lane 6). GnRH-I fusion protein (18.871 KD) of the second vaccine was detected both in cell lysate (lane 3) and cell culture supernatant (lane 7). GnRH-I fusion protein was not detected in any of the control lane 5, 9 and 10.

Article Snippet: A Kaleidoscope (Precision Plus ProteinTM BIO-RAD) protein marker was included in the starting wells and the separated protein bands in the gels were transferred to a nitrocellulose membrane (HybondTMECL membrane, Amersham Bioscience).

Techniques: Western Blot, Transfection, Vaccines, Cell Culture, Negative Control, Control